p53 (Ab-6) (Pantropic) Mouse mAb (DO-1) | EMD Millipore OP43 product information

This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.

product summary

company name :

EMD Millipore

other brands :

Oncogene Research Products, Calbiochem, Novagen, Merck, Upstate Biotechnology, Chemicon, LINCO, Novabiochem, Guava

product type :

antibody

product name :

p53 (Ab-6) (Pantropic) Mouse mAb (DO-1)

catalog :

OP43

conjugate :

nonconjugated

clone name :

DO-1

The same clone is also sold as:

Cell Signaling Technology: 18032
Bio-Rad: MCA1701B, MCA1701
BioLegend: 645704, 645701, 645702, 645705, 645703, 645706
MyBioSource: MBS212262
Santa Cruz Biotechnology: sc-126 X, sc-126 HRP, sc-126, sc-126 AC
BD Biosciences: 554293
Active Motif: 39553
Abcam: ab1101
LifeSpan Biosciences: LS-C339359, LS-C43827, LS-C179709, LS-C11553
MilliporeSigma: SAB5100001, P6874, P9124, P9249
OriGene: SM2137P, TA804804S, CF804804, TA804804, SM2137B
Invitrogen: AHO0152, MA5-12571

reactivity :

human

application :

western blot, immunocytochemistry, chromatin immunoprecipitation, other, western blot knockout validation

citations: 9

Published Application/Species/Sample/Dilution	Reference
western blot knockout validation; human; loading ...; fig 1e	Paculova H, Kramara J, Simečková S, Fedr R, Soucek K, Hylse O, et al. BRCA1 or CDK12 loss sensitizes cells to CHK1 inhibitors. Tumour Biol. 2017;39:1010428317727479 pubmed publisher
western blot knockout validation; human; loading ...; fig 1a	Kayama K, Watanabe S, Takafuji T, Tsuji T, Hironaka K, Matsumoto M, et al. GRWD1 negatively regulates p53 via the RPL11-MDM2 pathway and promotes tumorigenesis. EMBO Rep. 2017;18:123-137 pubmed publisher
western blot knockout validation; human; loading ...; fig 1e chromatin immunoprecipitation; human; loading ...; fig 4b	Rada M, Vasileva E, Lezina L, Marouco D, Antonov A, Macip S, et al. Human EHMT2/G9a activates p53 through methylation-independent mechanism. Oncogene. 2017;36:922-932 pubmed publisher
western blot; human; 1:500; loading ...; fig 9b	Lang A, Whongsiri P, Yilmaz M, Lautwein T, Petzsch P, Greife A, et al. Knockdown of UTX/KDM6A Enriches Precursor Cell Populations in Urothelial Cell Cultures and Cell Lines. Cancers (Basel). 2020;12: pubmed publisher
western blot; human; 1:1000; loading ...	Lieb S, Blaha Ostermann S, Kamper E, Rippka J, Schwarz C, Ehrenhöfer Wölfer K, et al. Werner syndrome helicase is a selective vulnerability of microsatellite instability-high tumor cells. elife. 2019;8: pubmed publisher
western blot; human; 1:1000; loading ...; fig 5b	Bitler B, Wu S, Park P, Hai Y, Aird K, Wang Y, et al. ARID1A-mutated ovarian cancers depend on HDAC6 activity. Nat Cell Biol. 2017;19:962-973 pubmed publisher
western blot; human; fig 1c	Miyamoto T, Lo P, Saichi N, Ueda K, Hirata M, Tanikawa C, et al. Argininosuccinate synthase 1 is an intrinsic Akt repressor transactivated by p53. Sci Adv. 2017;3:e1603204 pubmed publisher
immunocytochemistry; human; 1:1000; fig 3f western blot; human; fig 3a; 4c	Mori J, Tanikawa C, Ohnishi N, Funauchi Y, Toyoshima O, Ueda K, et al. EPSIN 3, A Novel p53 Target, Regulates the Apoptotic Pathway and Gastric Carcinogenesis. Neoplasia. 2017;19:185-195 pubmed publisher
	Yuneva M, Zamboni N, Oefner P, Sachidanandam R, Lazebnik Y. Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells. J Cell Biol. 2007;178:93-105 pubmed